Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-26

FDA Approved: FLUVASTATIN SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fluvastatin Sodium (generic Fluvastatin) from Mylan Pharmaceuticals Inc. (ANDA 090595), enabling its marketing as a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvastatin sodium (Fluvastatin sodium)

Snippet

SUPPL AP for FLUVASTATIN SODIUM (FLUVASTATIN)